Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis trial

Trial Profile

Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis trial

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Celecoxib (Primary) ; Paclitaxel; Zotarolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms mini-COREA
  • Most Recent Events

    • 08 Mar 2012 Primary endpoint 'Late-loss' has been met.
    • 13 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top